133 related articles for article (PubMed ID: 18711102)
41. [Gottron-like papules induced by sunitinib].
Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
[No Abstract] [Full Text] [Related]
42. Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma.
Rolleman EJ; Weening J; Betjes MG
Nephrol Dial Transplant; 2009 Jun; 24(6):2002-3. PubMed ID: 19332867
[No Abstract] [Full Text] [Related]
43. [Leg ulcerations and sunitinib].
Guyot-Caquelin P; Granel-Brocard F; Cuny JF; Trechot P; Spaeth D; Marchal A; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2010 Oct; 137(10):626-9. PubMed ID: 20932442
[TBL] [Abstract][Full Text] [Related]
44. Recurrent scrotal hemangiomas during treatment with sunitinib.
Tonini G; Intagliata S; Cagli B; Segreto F; Perrone G; Onetti Muda A; Santini D; Persichetti P
J Clin Oncol; 2010 Dec; 28(35):e737-8. PubMed ID: 20823408
[No Abstract] [Full Text] [Related]
45. Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.
Alexandrescu DT; McClure R; Farzanmehr H; Dasanu CA
J Clin Oncol; 2008 Aug; 26(24):4047-8. PubMed ID: 18711201
[No Abstract] [Full Text] [Related]
46. Guillain-Barré syndrome after treatment with sunitinib malate?
Mulherin B; Loconte NK; Holen KD
Oncology (Williston Park); 2008 Jan; 22(1):66-7, 70-1. PubMed ID: 18251284
[TBL] [Abstract][Full Text] [Related]
47. Sunitinib-induced pseudoporphyria.
Sanz-Motilva V; Martorell-Calatayud A; Llombart B; Requena C; Serra-Guillén C; Nagore E; Guillén C; Traves V; Sanmartín O
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1848-50. PubMed ID: 24813651
[No Abstract] [Full Text] [Related]
48. Colonic pneumatosis and intestinal perforations with sunitinib treatment for renal cell carcinoma.
Flaig TW; Kim FJ; La Rosa FG; Breaker K; Schoen J; Russ PD
Invest New Drugs; 2009 Feb; 27(1):83-7. PubMed ID: 18563296
[No Abstract] [Full Text] [Related]
49. Scrotal cutaneous side effects of sunitinib.
Billemont B; Barete S; Rixe O
N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
[No Abstract] [Full Text] [Related]
50. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab.
Ara M; Pastushenko E
Actas Dermosifiliogr; 2014 Dec; 105(10):900-12. PubMed ID: 24766821
[TBL] [Abstract][Full Text] [Related]
51. Sunitinib related osteonecrosis of jaw: a case report.
Fleissig Y; Regev E; Lehman H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):e1-3. PubMed ID: 22676833
[TBL] [Abstract][Full Text] [Related]
52. [Necrotizing hand-foot skin reaction induced by antiangiogenic in a patient with Thevenard neuroacropathy].
Durant C; Saint-Jean M; Connault J; Pistorius MA; Planchon B
J Mal Vasc; 2009 May; 34(3):222-5. PubMed ID: 19359111
[TBL] [Abstract][Full Text] [Related]
53. Sunitinib-induced thyrotoxicosis.
Piñar D; Boix E; Meana JA; Herrero J
J Endocrinol Invest; 2009 Dec; 32(11):941-2. PubMed ID: 19636224
[No Abstract] [Full Text] [Related]
54. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
55. Toxic dermatolysis, tissue necrosis and impaired wound healing due to sunitinib treatment leading to forefoot amputation.
Feyerabend S; Schilling D; Wicke C; Stenzl A
Urol Int; 2009; 82(2):246-8. PubMed ID: 19322019
[TBL] [Abstract][Full Text] [Related]
56. Heart failure associated with sunitinib: lessons learned from animal models.
Greineder CF; Kohnstamm S; Ky B
Curr Hypertens Rep; 2011 Dec; 13(6):436-41. PubMed ID: 21826469
[TBL] [Abstract][Full Text] [Related]
57. Scrotal cutaneous toxicity: an uncommon but important side-effect of sunitinib.
Gupta V; Rao A; Gupta S
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):132-3. PubMed ID: 25060046
[No Abstract] [Full Text] [Related]
58. Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib.
Rosenbaum SE; Wu S; Newman MA; West DP; Kuzel T; Lacouture ME
Support Care Cancer; 2008 Jun; 16(6):557-66. PubMed ID: 18274784
[TBL] [Abstract][Full Text] [Related]
59. Neurosensory retinal detachment due to sunitinib treatment.
Wegner A; Khoramnia R
Eye (Lond); 2011 Nov; 25(11):1517-8. PubMed ID: 21852804
[No Abstract] [Full Text] [Related]
60. CT halo sign and crazy paving pattern due to lung metastases hemorrhage after sunitinib therapy.
De Wulf S; Coulier B; Rezazadeh Azar A; Clausse M; Van Cutsem O; Frognier R
Diagn Interv Imaging; 2017 Jan; 98(1):93-95. PubMed ID: 27138072
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
